Rheumatoid Arthritis: The 45+ Market in the United States for Drugs and Biologics

Kalorama Information
November 1, 2003
190 Pages - SKU: KLI910423
License type:
Table of Contents Search inside this report Related Reports Buy by the Section

To purchase, check the box next to the section then click the "add section to cart" button. Learn more.

Rheumatoid Arthritis:The 45 Market in the United States for Drugs and Biologics
  • Executive Summary (pp. 13-24) US $211.00
  • Introduction (pp. 25-48) US $500.00
  • Rheumatoid Arthritis Therapeutics (pp. 49-108) US $1,673.00
  • Market Analysis (pp. 109-130) US $435.00
  • Company Profiles (pp. 131-176) US $1,021.00
  • Conclusions and Strategic Implications (pp. 177-188) US $269.00
  • Company Directory (pp. 189-202) US $236.00


 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Rheumatology/Arthritis Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!